click below
click below
Normal Size Small Size show me how
Infectious Disease 4
| CATEGORY | GENERIC NAME | BRAND NAME | INDICATIONS | SIDE EFFECTS | US BOXED WARNINGS | OTHER NOTES |
|---|---|---|---|---|---|---|
| Allylamine Antifungal | Terbinafine (PO, topical) | Lamisil (Topical:OTC) | Onychomycosis | Nausea, abdominal pain, diarrhea, elevated hepatic transaminases, headache | ||
| Azole Antifungal | Fluconazole (PO, IV) | Diflucan | Vulvovaginal candidiasis, oropharyngeal candidiasis, invasive candidiasis | Nausea, abdominal pain, diarrhea, QTc prolongation, elevated hepatic transaminases | ||
| Azole Antifungal | Ketoconazole (PO, topical) | Nizoral (topical:OTC) | Tinea infections | Nausea, abdominal pain, diarrhea, QTc prolongation, elevated hepatic transaminases | Serious hepatotoxicity, including cases with a fatal outcome or requiring liver transplantation have occurred; may cause QTc prolongation and drug interactions leading to QTc prolongation | |
| Polyene Antifungal | Nystatin (PO) | --- | Oropharyngeal candidiasis | Phlebitis, diarrhea, vomiting, anemia, fever | ||
| Polyene Antifungal | Nystatin (Topical) | Nystop | Cutaneous and mucocutaneous fungal infections | Burning, itching | Only use oral solutions for thrush | |
| Echinocandin Antifungal | Micafungin (IV) | Mycamine | Invasive candidiasis | No major side effects | ||
| Glucocorticoid and Azole Antiviral | betamethasone + clotrimazole | lotrisone | Cutaneous fungal infections | Burning, itching, dryness, skin atrophy | Do not use for diaper dermatitis; adrenal suppression with long-term use over large areas of skin | |
| Neuraminidase Inhibtor Antiviral | Oseltamivir (PO) | Tamiflu | Influenza | Nausea, vomiting, neuropsychiatric events (i.e., confusion, delirium, hallucinations) in pediatric patients (rare) | ||
| Antiviral | Acyclovir (PO, IV) | Zovirax | Herpes simplex virus | Nausea, increased hepatic transaminases, crystalluria | Vesicant | |
| Antiviral | Valacyclovir (PO) | Valtrex | Herpes simplex virus | Nausea, increased hepatic transaminases, crystalluria | Vesicant | |
| Antiviral | Nirmatrelvir + ritonavir (PO) | Paxlovid | COVID-19 | Diarrhea, dysgeusia | Significant drug interactions; strong CYP3A inhibitor | |
| Antiviral | Remdesivir (IV) | Veklury | COVID-19 | Hyperglycemia, renal impairment, bradycardia, increased liver enzymes, hypersensitivity | ||
| Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) | Emtricitabine + tenofovir disoproxil fumarate (PO) | Truvada | HIV infection, PreP, PEP | Decreased bone mineral density, kidney injury, nausea, diarrhea | Post treatment acute exacerbation of hepatitis B, risk of drug resistance with use for preexposure prophylaxis | |
| Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) and Integrase strand transfer inhibitor (INSTI) | Emtricitabine (NRTI) + tenofovir alafenamide (NRTI) + bictegravir (INSTI) (PO) | Biktarvy | HIV infection | Increased serum bilirubin, headache, weight gain, insomnia, diarrhea, nausea | Post treatment acute exacerbation of hepatitis B Other Notes: take oral INSTIs 2 hours before or 6 hours after products containing calcium, aluminum, magnesium, or iron |